The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Investigators from the Food and Drug Administration are working on a new Salmonella outbreak of unknown origin. The ...

Recently, the Government Accountability Office issued a report calling for a unified food safety strategy. There aren’t too ...

First-of-its-kind treatment to be approved by FDA in more than a decade, Pradalex is now available to treat swine and bovine respiratory diseases.

The company eliminated the dye back in 2013 and already offered 10 dye-free versions of its flavors. Recently, they added ...

Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.

Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...